TXG logo

10x Genomics (TXG) Operating profit

annual operating profit:

-$194.56M+$9.79M(+4.79%)
December 31, 2024

Summary

  • As of today (May 29, 2025), TXG annual operating income is -$194.56 million, with the most recent change of +$9.79 million (+4.79%) on December 31, 2024.
  • During the last 3 years, TXG annual operating profit has fallen by -$141.65 million (-267.70%).
  • TXG annual operating profit is now -991.74% below its all-time high of -$17.82 million, reached on December 31, 2018.

Performance

TXG Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGincome statement metrics

quarterly operating profit:

-$48.53M+$1.31M(+2.63%)
March 31, 2025

Summary

  • As of today (May 29, 2025), TXG quarterly operating income is -$48.53 million, with the most recent change of +$1.31 million (+2.63%) on March 31, 2025.
  • Over the past year, TXG quarterly operating profit has increased by +$12.97 million (+21.09%).
  • TXG quarterly operating profit is now -4244.15% below its all-time high of $1.17 million, reached on September 30, 2018.

Performance

TXG quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGincome statement metrics

TTM operating profit:

-$181.59M+$12.97M(+6.67%)
March 31, 2025

Summary

  • As of today (May 29, 2025), TXG TTM operating income is -$181.59 million, with the most recent change of +$12.97 million (+6.67%) on March 31, 2025.
  • Over the past year, TXG TTM operating profit has increased by +$32.27 million (+15.09%).
  • TXG TTM operating profit is now -15607.17% below its all-time high of $1.17 million, reached on September 30, 2018.

Performance

TXG TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTXGincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

TXG Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+4.8%+21.1%+15.1%
3 y3 years-267.7%-16.3%-114.6%
5 y5 years-569.3%-147.8%-291.3%

TXG Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-267.7%+4.8%-110.1%+23.4%-114.6%+15.1%
5 y5-year-569.3%+4.8%-1958.0%+23.4%-360.4%+15.1%
alltimeall time-991.7%+4.8%-4244.1%+23.4%<-9999.0%+15.1%

TXG Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
-$48.53M(-2.6%)
-$181.59M(-6.7%)
Dec 2024
-$194.56M(-4.8%)
-$49.84M(+20.1%)
-$194.56M(+7.9%)
Sep 2024
-
-$41.48M(-0.6%)
-$180.33M(-6.2%)
Jun 2024
-
-$41.74M(-32.1%)
-$192.24M(-10.1%)
Mar 2024
-
-$61.50M(+72.7%)
-$213.86M(+4.7%)
Dec 2023
-$204.35M(+21.7%)
-$35.61M(-33.3%)
-$204.35M(+6.5%)
Sep 2023
-
-$53.39M(-15.7%)
-$191.84M(+7.5%)
Jun 2023
-
-$63.36M(+21.9%)
-$178.44M(+0.1%)
Mar 2023
-
-$51.99M(+125.1%)
-$178.20M(+6.1%)
Dec 2022
-$167.94M(+217.4%)
-$23.10M(-42.3%)
-$167.94M(+4.5%)
Sep 2022
-
-$40.00M(-36.6%)
-$160.68M(+17.7%)
Jun 2022
-
-$63.12M(+51.2%)
-$136.56M(+61.4%)
Mar 2022
-
-$41.73M(+163.6%)
-$84.62M(+59.9%)
Dec 2021
-$52.91M
-$15.83M(-0.3%)
-$52.91M(+34.2%)
DateAnnualQuarterlyTTM
Sep 2021
-
-$15.88M(+42.1%)
-$39.44M(-17.6%)
Jun 2021
-
-$11.18M(+11.5%)
-$47.85M(-36.8%)
Mar 2021
-
-$10.03M(+325.2%)
-$75.77M(-11.2%)
Dec 2020
-$85.32M(+193.5%)
-$2.36M(-90.3%)
-$85.32M(-6.1%)
Sep 2020
-
-$24.29M(-37.9%)
-$90.90M(+20.1%)
Jun 2020
-
-$39.10M(+99.7%)
-$75.71M(+63.1%)
Mar 2020
-
-$19.58M(+146.7%)
-$46.41M(+59.6%)
Dec 2019
-$29.07M(+63.1%)
-$7.94M(-12.7%)
-$29.07M(+14.2%)
Sep 2019
-
-$9.10M(-7.1%)
-$25.46M(+67.6%)
Jun 2019
-
-$9.79M(+336.2%)
-$15.20M(+181.1%)
Mar 2019
-
-$2.25M(-48.2%)
-$5.41M(+71.0%)
Dec 2018
-$17.82M(-3.0%)
-$4.33M(-469.9%)
-$3.16M(-369.9%)
Sep 2018
-
$1.17M
$1.17M
Dec 2017
-$18.38M
-
-

FAQ

  • What is 10x Genomics annual operating income?
  • What is the all time high annual operating profit for 10x Genomics?
  • What is 10x Genomics annual operating profit year-on-year change?
  • What is 10x Genomics quarterly operating income?
  • What is the all time high quarterly operating profit for 10x Genomics?
  • What is 10x Genomics quarterly operating profit year-on-year change?
  • What is 10x Genomics TTM operating income?
  • What is the all time high TTM operating profit for 10x Genomics?
  • What is 10x Genomics TTM operating profit year-on-year change?

What is 10x Genomics annual operating income?

The current annual operating profit of TXG is -$194.56M

What is the all time high annual operating profit for 10x Genomics?

10x Genomics all-time high annual operating income is -$17.82M

What is 10x Genomics annual operating profit year-on-year change?

Over the past year, TXG annual operating income has changed by +$9.79M (+4.79%)

What is 10x Genomics quarterly operating income?

The current quarterly operating profit of TXG is -$48.53M

What is the all time high quarterly operating profit for 10x Genomics?

10x Genomics all-time high quarterly operating income is $1.17M

What is 10x Genomics quarterly operating profit year-on-year change?

Over the past year, TXG quarterly operating income has changed by +$12.97M (+21.09%)

What is 10x Genomics TTM operating income?

The current TTM operating profit of TXG is -$181.59M

What is the all time high TTM operating profit for 10x Genomics?

10x Genomics all-time high TTM operating income is $1.17M

What is 10x Genomics TTM operating profit year-on-year change?

Over the past year, TXG TTM operating income has changed by +$32.27M (+15.09%)
On this page